CXCL8 and colorectal carcinoma: We therefore aimed to investigate IL-8 release following treatment of CRC cells with additional apoptosis inducers, including Bortezomib, 5-Fluorouracil (5-FU) and Oxaliplatin, of which the latter two constitute the standard chemotherapy regimen for CRC patients [18].